Stop guessing. Get the definitive regulatory status of electronic consent and eSignature adoption across 33 major clinical trial markets.
The global regulatory landscape has reached unprecedented maturity, with 91% of assessed countries now supporting eConsent usage. Our updated whitepaper, eConsent Readiness in 33 Countries, provides clinical operations professionals with the clarity needed to confidently launch global hybrid and decentralized trials.
Discover the specific legislation (including 21 CFR Part 11, eIDAS, and ICH E6(R3) principles) that governs eConsent and eSignature adoption in every major jurisdiction, alongside practical guidance for compliance.
Stop wasting time navigating ambiguity. Download your free guide today and plan your next study with confidence.
